These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5285372)

  • 1. Differences in the metabolism of drugs depending upon their routes of administration.
    Dollery CT; Davies DS; Conolly ME
    Ann N Y Acad Sci; 1971 Jul; 179():108-14. PubMed ID: 5285372
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioavailability of propranolol in the dog.
    Tse FL; Sanders TM; Reo JP
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):180-9. PubMed ID: 7224706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of isoprenaline in dog and man.
    Conolly ME; Davies DS; Dollery CT; Morgan CD; Paterson JW; Sandler M
    Br J Pharmacol; 1972 Nov; 46(3):458-72. PubMed ID: 4656607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preferential deposition of inhaled isoproterenol and propranolol in asthmatic patients.
    Ruffin RE; Dolovich MB; Oldenburg FA; Newhouse MT
    Chest; 1981 Dec; 80(6 Suppl):904-7. PubMed ID: 6273074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of propranolol.
    Routledge PA; Shand DG
    Clin Pharmacokinet; 1979; 4(2):73-90. PubMed ID: 378502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological determinants of propranolol disposition in man.
    Kornhauser DM; Wood AJ; Vestal RE; Wilkinson GR; Branch RA; Shand DG
    Clin Pharmacol Ther; 1978 Feb; 23(2):165-74. PubMed ID: 620476
    [No Abstract]   [Full Text] [Related]  

  • 7. Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.
    Evans GH; Shand DG
    Clin Pharmacol Ther; 1973; 14(4):487-93. PubMed ID: 4723255
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of isoprenaline in the intestine.
    George CF; Blackwell EW; Davies DS
    J Pharm Pharmacol; 1974 Apr; 26(4):265-7. PubMed ID: 4151382
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of propranolol on the isoproterenol, responses of cortisol, isoproterenol, and aminophylline.
    Ohman JL; Lawrence M; Lowell FC
    J Allergy Clin Immunol; 1972 Sep; 50(3):151-6. PubMed ID: 5050326
    [No Abstract]   [Full Text] [Related]  

  • 10. Presystemic and systemic glucuronidation of propranolol.
    Walle T; Fagan TC; Conradi EC; Walle UK; Gaffney TE
    Clin Pharmacol Ther; 1979 Aug; 26(2):167-72. PubMed ID: 455886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption and elimination profile of isoproterenol. 3. The metabolic fate of dl-isoproterenol-7-3H in the dog.
    Conway WD; Minatoya H; Lands AM; Shekosky JM
    J Pharm Sci; 1968 Jul; 57(7):1135-41. PubMed ID: 5662050
    [No Abstract]   [Full Text] [Related]  

  • 12. Isoproterenol metabolism in children after intravenous administration.
    Kadar D; Tang HY; Conn AW
    Clin Pharmacol Ther; 1974 Nov; 16(5 Part 1):789-95. PubMed ID: 4426147
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.
    Cleaveland CR; Shand DG
    Clin Pharmacol Ther; 1972; 13(2):181-5. PubMed ID: 4401564
    [No Abstract]   [Full Text] [Related]  

  • 14. The quantitative assessment of isoprenaline metabolism in man.
    Morgan CD; Ruthven CR; Sandler M
    Clin Chim Acta; 1969 Dec; 26(3):381-6. PubMed ID: 5358537
    [No Abstract]   [Full Text] [Related]  

  • 15. The hemodynamic effects of beta adrenergic blockade on the flow-dependent hepatic clearance of propranolol.
    Nies AS; Evans GH; Shand DG
    J Pharmacol Exp Ther; 1973 Mar; 184(3):716-20. PubMed ID: 4631471
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological and metabolic studies with propranolol in man.
    Conolly ME; Paterson JW; Dollery CT; Hayes A; Cooper RG
    Clin Sci; 1970 Feb; 38(2):10P. PubMed ID: 5416143
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolism of the enantiomeric I-O-alkyl glycerol ethers in the rat intestinal mucosa in vivo; incorporation into I-O-alkyl and I-O-alk-I'-enyl glycerol lipids.
    Paltauf F
    Biochim Biophys Acta; 1971 Jun; 239(1):38-46. PubMed ID: 5569939
    [No Abstract]   [Full Text] [Related]  

  • 18. The metabolic fate of DL(7-3H)isoprenaline in man and dog.
    Morgan CD; Sandler M; Davies DS; Conolly M; Paterson JW; Dollery CT
    Biochem J; 1969 Aug; 114(1):8P. PubMed ID: 5810074
    [No Abstract]   [Full Text] [Related]  

  • 19. The subcellular binding of propranolol in rat heart.
    Masuoka D; Alcaraz A; Earle R
    J Pharm Pharmacol; 1967 Jul; 19(7):479-80. PubMed ID: 4382643
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo metabolism of 15 alpha-hydroxyprogesterone in man.
    Giannopoulos G; Durham LJ; Solomon S
    Biochemistry; 1970 Feb; 9(3):584-96. PubMed ID: 4906325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.